Open access
CHANGES IN MARKET POWER OF SELECTED PHARMACEUTICAL COMPANIES IN THE CONTEXT OF A GLOBAL BIOMEDICAL SHOCK
Mirosław GEISE1, Aldona UZIĘBŁO2
Publication language: English
Journal article
Transformations No. 4 (119) 2023, Publication date: 29 December 2023
Keywords: market power, global medical breakthrough, transnational corporations, mRNA vaccines.
Abstract This article aims to draw the reader's attention to the speed and intensity of the changes taking place in selected companies originating from the pharmaceutical sector, which in recent years have been involved in re-search and development for the use of m-RNA vaccines against various types of cancer. The research assumption is that this type of research re-quires significant financial resources and that the expected results are subject to a high risk of failure or lower results than expected. The article assumes that companies that have achieved spectacular business success through producing and distributing COVID-19 protective vaccines during the pandemic can use part of their retained profits to intensify research in-to developing personalised cancer vaccines. The biomedical breakthrough began at the end of 2020 when mRNA vaccines were introduced on a massive scale to combat the COVID-19 virus. Among the companies with the historically highest revenue and profit growth in 2021 were two entities, the US-based Moderna and Germany's BioNTech. The research hypothesis in the work presented here is that the intensive inhouse and implementation research into the use of mRNA vaccines to combat viral diseases con-ducted in the second decade of the 21st century and the multibillion dollar revenues accumulated from the sale of these specifics in a short period (2021) have created an excellent opportunity for the units under study to develop novel vaccines against various types of cancer.
Department of Economics, Faculty of Law and Economics, Kazimierz Wielki University in Bydgoszcz, Poland
ORCID: 0000-0002-8658-6617
E-mail: mgeise@o2.pl
Department of Economics, Faculty of Law and Economics, Kazimierz Wielki University in Bydgoszcz, Poland
ORCID: 0000-0003-0885-5014
E-mail: auzieblo@ukw.edu.pl